impact factor, citescore
logo
In press
In Press
Recent issue
Recent issue
Recent Supplement
Recent supplement
archives
Archives
articles free
Free to view
Search
Search
 

Letters to the Editor

 

Janus kinase inhibitor tofacitinib is a potential therapeutic option for refractory eosinophilic fasciitis

1, 2, 3, 4, 5

 

  1. Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
  2. Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. zjlpumc@163.com
  3. Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. houyongjia@hotmail.com
  4. Department of Radiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
  5. Department of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.

CER12747
2020 Vol.38, N°3
PI 0567, PF 0568
Letters to the Editor

Free to view
(click on article PDF icon to read the article)

PMID: 31820721 [PubMed]

Received: 06/09/2019
Accepted : 30/09/2019
In Press: 18/11/2019
Published: 27/05/2020

Rheumatology Article